As Banco Macro Sa (BMA) Share Value Rose, Shareholder Pointstate Capital LP Increased Its Position

March 14, 2018 - By Jan Rainey

Pointstate Capital Lp increased its stake in Banco Macro Sa (BMA) by 8.11% based on its latest 2017Q3 regulatory filing with the SEC. Pointstate Capital Lp bought 139,293 shares as the company’s stock rose 7.03% with the market. The hedge fund held 1.86M shares of the commercial banks company at the end of 2017Q3, valued at $217.93M, up from 1.72 million at the end of the previous reported quarter. Pointstate Capital Lp who had been investing in Banco Macro Sa for a number of months, seems to be bullish on the $7.32B market cap company. The stock decreased 0.46% or $0.51 during the last trading session, reaching $109.46. About 187,938 shares traded. Banco Macro S.A. (NYSE:BMA) has risen 43.80% since March 14, 2017 and is uptrending. It has outperformed by 27.10% the S&P500.

Pointstate Capital Lp, which manages about $10.76B and $11.77B US Long portfolio, decreased its stake in Grupo Financiero Galicia S A (NASDAQ:GGAL) by 1.49 million shares to 940,704 shares, valued at $48.48M in 2017Q3, according to the filing. It also reduced its holding in Sba Communications Corp New by 728,031 shares in the quarter, leaving it with 377,169 shares, and cut its stake in Sarepta Therapeutics Inc (NASDAQ:SRPT).

More recent Banco Macro S.A. (NYSE:BMA) news were published by: which released: “Banco Macro SA ADR BMA (US: NYSE)” on February 12, 2011. Also published the news titled: “Validea Martin Zweig Strategy Daily Upgrade Report – 2/22/2018” on November 10, 2017.‘s news article titled: “Banco Macro SA Sponsored ADR Class B to Host Earnings Call” with publication date: February 21, 2018 was also an interesting one.

Banco Macro S.A. (NYSE:BMA) Ratings Coverage

Among 5 analysts covering Banco Macro SA (NYSE:BMA), 1 have Buy rating, 0 Sell and 4 Hold. Therefore 20% are positive. Banco Macro SA had 7 analyst reports since February 9, 2016 according to SRatingsIntel. As per Wednesday, June 1, the company rating was initiated by UBS. The firm has “Hold” rating by Goldman Sachs given on Monday, September 11. The rating was upgraded by Goldman Sachs on Monday, September 26 to “Buy”. Credit Suisse upgraded the stock to “Buy” rating in Tuesday, June 13 report. Credit Suisse initiated the shares of BMA in report on Tuesday, March 29 with “Neutral” rating. The firm earned “Neutral” rating on Monday, May 23 by Citigroup.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: